Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXB3AP
|
||||
Drug Name |
Dimethyl-[3-(1-phenyl-1H-benzoimidazol-5-yloxy)-propyl]-amine
|
||||
Synonyms |
CHEMBL312269
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C18H21N3O
|
||||
Canonical SMILES |
CN(C)CCCOc1ccc2c(c1)ncn2c3ccccc3
|
||||
InChI |
InChI=1S/C18H21N3O/c1-20(2)11-6-12-22-16-9-10-18-17(13-16)19-14-21(18)15-7-4-3-5-8-15/h3-5,7-10,13-14H,6,11-12H2,1-2H3
|
||||
InChIKey |
TVCMMAFYYAKVLR-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Basic fibroblast growth factor receptor 1 | Target Info | [1587926] | ||
Platelet-derived growth factor receptor | Target Info | [1587926] | |||
KEGG Pathway | MAPK signaling pathway | ||||
Ras signaling pathway | |||||
Rap1 signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
Adherens junction | |||||
Signaling pathways regulating pluripotency of stem cells | |||||
Regulation of actin cytoskeleton | |||||
Pathways in cancer | |||||
Proteoglycans in cancer | |||||
Prostate cancer | |||||
Melanoma | |||||
Central carbon metabolism in cancer | |||||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
FGF signaling pathway | |||||
Pathway Interaction Database | Glypican 1 network | ||||
Syndecan-4-mediated signaling events | |||||
N-cadherin signaling events | |||||
FGF signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.